[Hinews] SEOUL, South Korea — All four hospitals affiliated with Hallym University Medical Center—Hallym University Sacred Heart Hospital, Kangnam Sacred Heart Hospital, Chuncheon Sacred Heart Hospital, and Dongtan Sacred Heart Hospital—achieved top results in the 2023 breast and liver cancer care assessments (second-cycle, first-round) conducted by South Korea’s Health Insurance Review and Assessment Service (HIRA).
The latest evaluation reflected shifts in cancer care—such as diversified treatment approaches and rising long-term survival rates—and introduced a comprehensive overhaul of its metrics and scope. Moving beyond a surgery-centric focus, the assessment now encompasses the entire spectrum of cancer care, with an increased emphasis on treatment outcomes and patient-centered metrics.
In the breast cancer evaluation, which included 138 institutions, all four Hallym-affiliated hospitals secured the highest grade of 1. Hallym University Sacred Heart Hospital scored 94.5, Kangnam Sacred Heart Hospital 94.6, Chuncheon Sacred Heart Hospital 96.2, and Dongtan Sacred Heart Hospital 95.6—each surpassing the average scores for tertiary and general hospitals.
Hallym University Medical Center recognized for top performance in HIRA’s breast and liver cancer care assessment. (Photo courtesy of Hallym University Medical Center
Kangnam Sacred Heart Hospital stood out, earning perfect scores in specialist staffing, multidisciplinary care, patient education and counseling, and pathology report documentation—underscoring its strong medical capabilities.
The liver cancer evaluation, involving 175 institutions, also saw strong performances from all four Hallym hospitals. This assessment expanded to 15 indicators, covering both general and liver cancer-specific measures, and shifted from assigning grades to providing detailed performance evaluations. Hallym University Sacred Heart Hospital earned perfect scores in key areas such as specialist staffing, timely surgeries within 30 days of diagnosis, patient education and counseling, and post-treatment follow-up testing. These results highlight the hospital’s expertise and systematic approach to liver cancer care.
The results highlight Hallym University Medical Center’s commitment to high-quality, patient-focused cancer care across its network, positioning its hospitals as leaders in South Korea’s evolving oncology landscape.
